Does DENOSUMAB Cause Neoplasm malignant? 698 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 698 reports of Neoplasm malignant have been filed in association with DENOSUMAB (Bilprevda). This represents 0.5% of all adverse event reports for DENOSUMAB.
698
Reports of Neoplasm malignant with DENOSUMAB
0.5%
of all DENOSUMAB reports
152
Deaths
78
Hospitalizations
How Dangerous Is Neoplasm malignant From DENOSUMAB?
Of the 698 reports, 152 (21.8%) resulted in death, 78 (11.2%) required hospitalization, and 6 (0.9%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DENOSUMAB. However, 698 reports have been filed with the FAERS database.
What Other Side Effects Does DENOSUMAB Cause?
Off label use (34,612)
Death (16,545)
Osteonecrosis of jaw (8,438)
Arthralgia (5,890)
Pain in extremity (4,541)
Back pain (4,465)
Pain (4,102)
Product storage error (3,621)
Fall (3,322)
Fatigue (3,009)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which DENOSUMAB Alternatives Have Lower Neoplasm malignant Risk?
DENOSUMAB vs DEOXYCHOLIC ACID
DENOSUMAB vs DEPAKINE CHRONO
DENOSUMAB vs DEPAKOTE
DENOSUMAB vs DEPO-PROVERA
DENOSUMAB vs DERMATOPHAGOIDES FARINAE